[1]Jonk LJ, de Jonge ME, Vervaart JM, et al. Isolation and developmental expression of retinoic-acid-induced genes[J]. Dev Biol, 1994,161:604-614. [2]Werner S, Brors B, Eick J, et al. Suppression of early hematogenous dissemination of human breast cancer cells to bone marrow by retinoic acid-induced 2 [J]. Cancer Discov, 2015,5:506-519. [3]Besler K, Węglarz A, Keller L, et al. Expression patterns and corepressor function of retinoic acid-induced 2 in prostate cancer[J]. Clin Chem, 2022,68:973-983. [4]Zhang W, Kong L, Zhu H, et al. Retinoic acid-induced 2 (RAI2) is a novel antagonist of Wnt/β-Catenin signaling pathway and potential biomarker of chemosensitivity in colorectal cancer[J]. Front Oncol, 2022,12:805290. doi: 10.3389/fonc.2022.805290. [5]Walpole SM, Hiriyana KT, Nicolaou A, et al. Identification and characterization of the human homologue (RAI2) of a mouse retinoic acid-induced gene in Xp22[J]. Genomics, 1999,55:275-283. [6]Esposito M, Kang Y. RAI2: linking retinoic acid signaling with metastasis suppression[J]. Cancer Discov, 2015,5:466-468. [7]Yan W, Wu K, Herman JG, et al. Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer[J]. Clin Epigenetics, 2018,10:69. doi: 10.1186/s13148-018-0501-4. [8]Nishikawa S, Uemoto Y, Kim TS, et al. Low RAI2 expression is a marker of poor prognosis in breast cancer[J]. Breast Cancer Res Treat, 2021,187:81-93. [9]Yang C, Mou Z, Zhang Z, et al. Circular RNA RBPMS inhibits bladder cancer progression via miR-330-3p/RAI2 regulation[J]. Mol Ther Nucleic Acids, 2021,23:872-886. [10]Huang M, Ding J, Wu X, et al. EZH2 affects malignant progression and DNA damage repair of lung adenocarcinoma cells by regulating RAI2 expression[J]. Mutat Res, 2022,825:111792. doi: 10.1016/j.mrfmmm.2022.111792. [11]Yu Y, Lu X, Yan Y, et al. The lncRNA KIF9-AS1 accelerates hepatocellular carcinoma growth by recruiting DNMT1 to promote RAI2 DNA methylation[J]. J Oncol, 2022,2022:3888798. doi: 10.1155/2022/3888798. [12]Gelissen JH, Huang GS. Intersections of endocrine pathways and the epithelial mesenchymal transition in endometrial cancer[J]. Front Oncol,2022,12: 914405. doi: 10.3389/fonc.2022.914405. |